ArticleFrontiers in immunology2026
FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures presenting with postictal purpura and rhabdomyolysis: a case report.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures (FLAMES) represent a rare and distinctive clinico-radiological syndrome. Here, we report the case of a 35-year-old man who presented with sudden-onset generalized tonic-clonic seizures. Brain magnetic resonance imaging revealed cortical FLAIR hyperintensities in the right parietal lobe. During hospitalization, he developed scattered petechiae over the neck and chest, accompanied by elevated creatine kinase (CK) levels, findings that initially raised concern for systemic vasculitis or inflammatory myopathy. Given the close temporal relationship to the seizures, together with negative autoimmune and infectious evaluations, these abnormalities were ultimately interpreted as postictal purpura and seizure-associated rhabdomyolysis. Subsequent investigations confirmed serum positivity for anti-MOG antibodies, while antinuclear antibody profiling, vasculitis-related markers, and microbiological screening were all negative. After high-dose intravenous methylprednisolone therapy, seizure activity was controlled, the petechial rash resolved, CK levels normalized, and the cortical lesions showed marked regression on follow-up imaging. This case highlights that FLAMES may be complicated by postictal purpura and rhabdomyolysis, underscoring the potential for diagnostic confusion with systemic inflammatory disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.